Globus Medical A Stock Price To Earning
| GM0N Stock | EUR 78.00 2.00 2.50% |
GLOBUS MEDICAL A fundamentals help investors to digest information that contributes to GLOBUS MEDICAL's financial success or failures. It also enables traders to predict the movement of GLOBUS Stock. The fundamental analysis module provides a way to measure GLOBUS MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GLOBUS MEDICAL stock.
GLOBUS |
GLOBUS MEDICAL A Company Price To Earning Analysis
GLOBUS MEDICAL's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, GLOBUS MEDICAL A has a Price To Earning of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
GLOBUS Fundamentals
| Current Valuation | 6.66 B | |||
| Price To Book | 4.15 X | |||
| Price To Sales | 7.57 X | |||
| Revenue | 1.02 B | |||
| EBITDA | 304.5 M | |||
| Net Income | 190.17 M | |||
| Cash Flow From Operations | 178.47 M | |||
| Price To Earnings To Growth | 2.80 X | |||
| Number Of Employees | 12 | |||
| Market Capitalization | 6.1 B | |||
| Total Asset | 2.08 B | |||
| Net Asset | 2.08 B |
About GLOBUS MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GLOBUS MEDICAL A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GLOBUS MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GLOBUS MEDICAL A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GLOBUS Stock
GLOBUS MEDICAL financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL security.